Acylcarnitine, Quant Plasma ACYL

Synonyms
Allscripts (AEHR) Order Name	Acyl Carnitine, Plasma
Sunrise Clinical Manager (SCM) Order Name	Acyl Carnitine, Plasma
Clinical Info	Used in the diagnosis and monitoring of inherited disorders of fatty acid oxidation and organic acidurias. May be used as a follow-up test to some abnormal newborn screen results.
Specimen Type	Blood
Container	Green Top Tube
Collection Instructions	Container/Tube: Green-top (sodium heparin) Specimen: 1 mL plasma (minimum volume: 0.1 mL) Transport Temperature: Frozen Stability: 2 - 8 Weeks Frozen Note: Centrifuge immediately after collection and pour off plasma in transport vial. Freeze immediately.
Transport Instructions	Frozen
Specimen Stability	2 - 8 Weeks Frozen Note: Centrifuge immediately after collection and pour off plasma in transport vial. Freeze immediately.
Methodology	Flow injection/tandem mass spectrometry
Days Performed
Performing Laboratory	LabCorp
CPT	82017
PDM	5910515
Result Interpretation See report. TAT 4 - 7 Days Units: umol/L Includes: C2 ,C3, C3-Dicarboylic, C4, C4-Hydroxy, C4-Dicarboxylic, C5, C5:1, c5-Hydroxy, C5-Dicarboxylic, C6, C8, C10, C10:1, C10:2, C12, C14, C14:1, C14:2 ,C14-Hydroxy, C16, C16:1, C16:1-Hydroxy, C16-Hydroxy, C18, C18:1, C18:2, C18-Hydroxy, C18:1-Hydroxy, C18:2-Hydroxy Limitations False-negative results can occur with acylcarnitine profiling, especially when the patient is carnitine deficient, is affected with a milder variant of a disorder, or when clinical condition or dietary supplementation causes secondary changes to the profile. Results of acylcarnitine profiling should be interpreted in the context of clinical presentation as well as other laboratory tests, which may include urine organic acid analysis and molecular testing. This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).
Forms